Company now has 44 dispensaries in Florida and 123 nationwide
WAKEFIELD, Mass., Jan. 19, 2022 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced plans to open two new dispensaries in Florida by the end of this month. The expansion will increase the Company's retail footprint to 44 dispensaries statewide and 123 across the country.
Curaleaf Tampa Bay Mabry, located at 13755 North Dale Mabry Highway, opened on January 15th and Curaleaf Largo, located at 10289 Ulmerton Road, is expected to open later this month, subject to final regulatory approvals. In December, Curaleaf added four additional dispensaries in Stuart, Lady Lake, Wesley Chapel and Miami to continue to expand access to the company's quality products and services.
Florida has evolved into one of the largest and fastest growing medical markets in the country. Curaleaf has quickly expanded its retail presence and cultivation footprint and introduced more innovative products, including Select Squeeze, Select Bites, Select Nano Bites, and its breakthrough vape hardware Cliq by Select, which features a proprietary gravity-fed pod and variable battery voltage settings, allowing patients to customize cannabis consumption experiences to their individual preferences. The company's Florida growth strategy resulted in significant gains last year, with Curaleaf doubling its market share to fifteen percent in the state.
"We are excited to kick off this year continuing our momentum of expansion and growth in Florida," said Matt Darin, President of Curaleaf. "Throughout this year our patients can expect to see Curaleaf continue to lead the Florida market with new innovative products and convenient new locations."
For more information on Curaleaf's latest openings in Florida, along with product offerings and hours of operation, please visit www.curaleaf.com/locations/#florida.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 123 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of two new dispensaries in the state of Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed April 28, 2021, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
INVESTOR CONTACT
Curaleaf Holdings, Inc.
Investor Relations
IR@curaleaf.com
MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
media@curaleaf.com
SOURCE Curaleaf Holdings, Inc.
